Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Antibody 130

Antibody DNA Development Vaccination 130

pharmaphorum

AUGUST 28, 2020

At this moment, people recognise that monitoring infectious diseases, in the US or globally, is challenging because data takes time. People get sick, the data goes into health records, the laboratory confirmations end up in Centers for Disease Control (CDC) and the ministries of health, and eventually with world bodies. Digital COVID.

Medicine 71

Medicine Research 71

pharmaphorum

JANUARY 21, 2022

Flawed funding model. Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Medicine 52

Medicine Marketing Manufacturing Production 52

The Pharma Data

MARCH 23, 2022

Unfortunately, in a Phase 3 clinical trial, treatment with remdesivir did not make a difference in mortality for Ebola virus disease patients. This special enzyme, once fused to Ebola virus polymerase, enables the polymerase to add a molecular tag to any other protein it interacts with.

Protein 52

Protein Genome Genomics Research 52

XTalks

OCTOBER 12, 2022

Features of blood perfusion in the brain detected by MRI now have clinical applications in central nervous system (CNS) cancers, neurodegenerative disease, cerebrovascular disease and demyelinating disease. An overview of the ASL MR perfusion technique to obtain cerebral blood flow (CBF) values.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

JUNE 2, 2021

It added that there is evidence that Evrysdi is a life-extending treatment for SMA type 1, the most serious from of the disease that generally leads to death before the age of 2 if untreated, and as an oral drug is an alternative for people who cannot have the other SMA treatment options.

Gene Therapy 52

Gene Therapy Gene Drugs Medicine 52

pharmaphorum

JANUARY 31, 2023

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. This dual model will empower patients to become more actively involved in their treatment decisions and will rebuild their trust in the pharmaceutical industry.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

NOVEMBER 28, 2022

The results of the collaboration were announced earlier this year, showing that the collaboratively trained AI outperformed single-partner models on multiple axes. A number of companies have sprung up offering AI models to help pharma companies with drug discovery over the past few years.

Pharma Companies 72

Pharma Companies Life Science Research Development 72

Pharmaceutical Technology

JANUARY 27, 2023

Sanofi’s eligibility requirements follow a similar model to Pfizer’s previous programs, with refunds being dependent on lack of clinical outcome in patients. A refund up to 12 inpatient doses will also be offered for patients whose disease worsens while receiving treatment. Currently, Cablivi’s WAC is $7,300 per single-dose vial kit.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

AUGUST 19, 2022

But bluebird bio has said such setbacks are expected for a company at the frontier of developing gene therapies for rare diseases. The most severe form of the disease is sometimes called transfusion-dependent beta-thalassemia or beta-thalassemia major. Zynteglo’s hefty price tag of $2.8

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

Rethinking Clinical Trials

NOVEMBER 6, 2023

Moyer, PhD Statistician, NIH Office of Disease Prevention Moderator: Andrea J. The results of this analysis suggest that crossed designs protect the type I error rate, allow flexibility in analytic models, and provide good power with sufficient sample size. Speaker Jonathan C.

Trials 130

Trials Clinical Trials Clinical Trials Contamination 130

Drug Discovery World

FEBRUARY 9, 2023

At the same time, we are developing a better understanding of disease pathology, leading to a more complicated picture of how diseases manifest. The first is that in-roads made in decoding the complexity of human disease will make drug discovery more difficult and costly, limiting the potential to develop new life-saving therapies.

Drugs 52

Drugs Development Big Data Scientist 52

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. These can be used to personalize the efficacy of the treatment.

DNA 66

DNA Radiology FDA Approval Development 66

pharmaphorum

NOVEMBER 19, 2021

The market is becoming tougher to enter as we control the outbreak and the main vaccines become more dominant,” says Mike Breen, director of infectious diseases and ophthalmology at GlobalData. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Pfizer is understood to have charged $19.50

Sales 137

Sales Vaccination Vaccine Marketing 137

Drug Discovery World

OCTOBER 28, 2022

Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models. . Click’ chemistry used to tag proteins made by cancer cells . Millions invited to join UK’s largest health research programme . Experimental monoclonal antibodies block EBV infection .

Drugs 52

Drugs Antibody Protein RNA 52

XTalks

DECEMBER 21, 2022

This included greater adoption and acceptance of decentralized clinical trial models, emphasis on patient-centric approaches in trials, growing digitization of healthcare and dealing with drug manufacturing challenges. There is also generally a low cost of return for gene therapies, particularly those for rare diseases.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Drug Discovery World

NOVEMBER 13, 2023

PLM and generative modelling for de novo degisn This session will begin with chairperson’s remarks from Victor Greiff, PhD, Associate Professor, Immunology, University of Oslo. Ali Madani, PhD, Founder and CEO, Profluent Bio, on: ‘Protein engineering with large language models’.

Protein 59

Protein Antibody Engineer Scientist 59

pharmaphorum

DECEMBER 7, 2021

Scientists in the US have found that people who use Viagra for erectile dysfunction seem to have a lower risk of developing Alzheimer’s disease – a link that they say should be examined more closely in clinical trials.

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52

Drug Discovery World

NOVEMBER 9, 2023

Advances in discovery and engineering of antibodies for non-cancer targets This session will feature a range of presentations which include: Joshua Tan, PhD, Chief, Antibody Biology Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on: ‘Discovery of broadley-neutralising antibodies against Coronaviruses’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

XTalks

FEBRUARY 11, 2021

Without the inclusion of Franklin’s opinion on the topic, it was agreed that the DNA model would be published as the work of Watson and Crick, while supporting data from Wilkins and Franklin was published as two separate papers. In April 1953, the journal Nature published a set of three historical papers on the structure of DNA.

Genetics 119

Genetics DNA Genome Genomics 119